DENTSPLY International (XRAY) : Cidel Asset Management Inc scooped up 10,849 additional shares in DENTSPLY International during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 3, 2016. The investment management firm now holds a total of 254,930 shares of DENTSPLY International which is valued at $16,606,140.DENTSPLY International makes up approximately 0.94% of Cidel Asset Management Inc’s portfolio.
Other Hedge Funds, Including , Her Majesty The Queen In Right Of The Province Of Alberta… reduced its stake in XRAY by selling 57,080 shares or 65.09% in the most recent quarter. The Hedge Fund company now holds 30,615 shares of XRAY which is valued at $1,994,261. DENTSPLY International makes up approx 0.03% of Her Majesty The Queen In Right Of The Province Of Alberta…’s portfolio.Boston Private Wealth reduced its stake in XRAY by selling 486 shares or 0.8% in the most recent quarter. The Hedge Fund company now holds 59,895 shares of XRAY which is valued at $3,901,560. DENTSPLY International makes up approx 0.15% of Boston Private Wealth’s portfolio.Proficio Capital Partners reduced its stake in XRAY by selling 10 shares or 18.18% in the most recent quarter. The Hedge Fund company now holds 45 shares of XRAY which is valued at $2,882.Bnp Paribas Arbitrage Sa reduced its stake in XRAY by selling 49,343 shares or 67.44% in the most recent quarter. The Hedge Fund company now holds 23,825 shares of XRAY which is valued at $1,510,267. DENTSPLY International makes up approx 0.01% of Bnp Paribas Arbitrage Sa’s portfolio.
DENTSPLY International closed down -1.09 points or -1.76% at $60.9 with 21,45,574 shares getting traded on Monday. Post opening the session at $61.89, the shares hit an intraday low of $60.74 and an intraday high of $62.17 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, DENTSPLY International reported $0.76 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Aug 5, 2016. Analyst had a consensus of $0.70. The company had revenue of $1022.00 million for the quarter, compared to analysts expectations of $1028.82 million. The company’s revenue was up 46.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.73 EPS.
Many Wall Street Analysts have commented on DENTSPLY International. DENTSPLY International was Downgraded by Barrington Research to ” Mkt Perform” on Aug 8, 2016. DENTSPLY International was Initiated by Piper Jaffray to “Overweight” on Jun 13, 2016. Company shares were Reiterated by Barrington Research on May 13, 2016 to “Outperform”, Firm has raised the Price Target to $ 68 from a previous price target of $62 .
DENTSPLY International Inc. is a designer developer manufacturer and marketer of a range of consumable dental products for the professional dental market. It operates through three segments: Dental Consumable and Certain International Businesses; Dental Specialty and Laboratory and Certain Global Distribution Businesses and Healthcare and Emerging Markets Businesses. All the segments are primarily engaged in the design manufacture and distribution of dental and medical products in four product categories. Its Dental Consumable Products consist of dental supplies and devices and small equipment used in dental offices. Its Dental Laboratory Products are used in the preparation of dental appliances by dental laboratories. Its Dental Specialty Products are specialized treatment products used within the dental office and laboratory settings. Its Consumable Medical Device Products consist mainly of urology catheters certain surgical products medical drills and other products.